Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A.

Authors: M J Elliott; R N Maini; M Feldmann; A Long-Fox; P Charles; P Katsikis; F M Brennan; J Walker; H Bijl; J Ghrayeb
Journal: Arthritis Rheum Date: 1993-12

9. The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis.

Authors: L J Howe; M R Stanford; C Edelsten; E M Graham
Journal: Eye (Lond) Date: 1994 Impact factor: 3.775

10. FK506 treatment of noninfectious uveitis.

Authors: M Ishioka; S Ohno; S Nakamura; K Isobe; N Watanabe; Y Ishigatsubo; S Tanaka
Journal: Am J Ophthalmol Date: 1994-12-15 Impact factor: 5.258

15 in total

Review 1. Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.

Authors: A D Dick; J D Isaacs
Journal: Br J Ophthalmol Date: 1999-11 Impact factor: 4.638

2. The prevalence of sight-threatening uveitis in Scotland.

Authors: G J Williams; S Brannan; J V Forrester; M P Gavin; S P Paterson-Brown; A T Purdie; M Virdi; J A Olson
Journal: Br J Ophthalmol Date: 2006-08-17 Impact factor: 4.638

Review 3. Management of uveitis in pediatric patients: special considerations.

Authors: Justine R Smith
Journal: Paediatr Drugs Date: 2002 Impact factor: 3.022

Review 4. Chronic non-infectious uveitis in the elderly: epidemiology, pathophysiology and management.

Authors: Rajen Gupta; Philip I Murray
Journal: Drugs Aging Date: 2006 Impact factor: 3.923

5. Campath-1H therapy in refractory ocular inflammatory disease.

Authors: A D Dick; P Meyer; T James; J V Forrester; G Hale; H Waldmann; J D Isaacs
Journal: Br J Ophthalmol Date: 2000-01 Impact factor: 4.638

Review 6. The Use of Biologic Therapies in Uveitis.

Authors: Sergio Schwartzman; Monica Schwartzman
Journal: Clin Rev Allergy Immunol Date: 2015-12 Impact factor: 8.667

7. Combined cyclosporin-A /prednisone therapy of patients with active uveitis suppresses IFN-gamma production and the function of dendritic cells.

Authors: M A Frassanito; R Dammacco; T Fusaro; A Cusmai; S Guerriero; C Sborgia
Journal: Clin Exp Immunol Date: 2003-08 Impact factor: 4.330

Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A.

Review 1. FK506 and cyclosporin, molecular probes for studying intracellular signal transduction.

2. Combined cyclosporin A-steroid-MTX treatment in endogenous non-infectious uveitis.

Review 3. The use of monoclonal antibodies to achieve immunological tolerance.

Review 4. Ocular involvement in toxoplasmosis.

5. Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease.

6. Immunocytochemical analysis of blood lymphocytes in uveitis.

7. Treatment of severe refractory uveitis with intravenous cyclophosphamide.

8. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.